Valeant Pharma (VRX) Will Report Q2 Results on August 9th
Tweet
Share
E-mail
Get Alerts VRX Hot Sheet
Price: $23.40 --0%
Financial Fact:
Income from discontinued operations attributable to Valeant: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Income from discontinued operations attributable to Valeant: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Valeant Pharma (NYSE: VRX) announced that it plans to host a conference call and live webcast on August 9, 2016 to discuss second quarter 2016 financial results.
Conference Call Details:
Date | Tuesday, August 9, 2016 |
Time | 8:00 a.m. ET |
Webcast | |
Participant Event Dial-in | (877) 876-8393 (North America) |
(973) 200-3961 (International) | |
Participant Passcode | 48835456 |
Replay Dial-in | (855) 859-2056 (North America) |
(404) 537-3406 (International) | |
Replay Passcode | 48835456 (Replay available until August 17, 2016) |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Berenberg Downgrades Berkeley Group Holdings Plc. (BKG:LN) (BKGFF) to Hold
- Berenberg Upgrades Barratt Redrow PLC (BTRW:LN) (BTDPY) to Buy
Create E-mail Alert Related Categories
Conference Calls, Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
